TY  - GEN
AU  - Lozano-Ojalvo, Daniel
AU  - Camara, Carmen
AU  - Lopez-Granados, Eduardo
AU  - Nozal, Pilar
AU  - Del Pino-Molina, Lucía
AU  - Bravo-Gallego, Luz Yadira
AU  - Paz-Artal, Estela
AU  - Pion, Marjorie
AU  - Correa-Rocha, Rafael
AU  - Ortiz, Alberto
AU  - Lopez-Hoyos, Marcos
AU  - Iribarren, Marta Erro
AU  - Portoles, Jose
AU  - Rojo-Portoles, Maria Pilar
AU  - Ojeda, Gloria
AU  - Cervera Hernandez, Isabel
AU  - Gonzalez-Perez, Maria
AU  - Bodega-Mayor, Irene
AU  - Montes-Casado, Maria
AU  - Portoles, Pilar
AU  - Perez-Olmeda, Mayte
AU  - Oteo-Iglesias, Jesus
AU  - Sanchez-Tarjuelo, Rodrigo
AU  - Pothula, Venu
AU  - Schwarz, Megan
AU  - Brahmachary, Manisha
AU  - Tan, Anthony Tanoto
AU  - Le Bert, Nina
AU  - Berin, Cecilia
AU  - Bertoletti, Antonio
AU  - Guccione, Ernesto
AU  - Ochando, Jordi
PY  - 2021
DO  - 10.1016/j.celrep.2021.109570
UR  - http://hdl.handle.net/20.500.12105/14165
AB  - The rapid development of mRNA-based vaccines against the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to the design of accelerated vaccination schedules that have been extremely effective in naive individuals. While a two-dose...
LA  - eng
PB  - Cell Press
KW  - BNT162b2 vaccine
KW  - COVID-19
KW  - SARS-CoV-2
KW  - T-cell immunity
TI  - Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals
TY  - research article
ER  -